Joinn Laboratories(China)Co.,Ltd.
603127
株式のランク
#3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
株価
$6.82
時価総額
$4.30B
変化（1日）
-6.30%
変化（1年）
48.79%
国
CN
取引 Joinn Laboratories(China)Co.,Ltd. (603127)
カテゴリー
Healthcare
Joinn Laboratories(China)Co.,Ltd.（603127）の配当利回りの履歴
Joinn Laboratories(China)Co.,Ltd.（銘柄コード: 603127）の配当利回り（TTM）は2024-12-31時点で0.97%です。
過去5年間の平均配当利回り: 0.59%
過去5年間の平均配当利回り: 0.59%
Joinn Laboratories(China)Co.,Ltd.（603127）の2012から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.26% | 188.89% |
| 2025 | 0.09% | -90.72% |
| 2024 | 0.97% | -22.40% |
| 2023 | 1.25% | 184.09% |
| 2022 | 0.44% | 100.00% |
| 2021 | 0.22% | -8.33% |
| 2020 | 0.24% | -35.14% |
| 2019 | 0.37% | -17.78% |
| 2018 | 0.45% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 0.33% | -73.39% |
| 2014 | 1.24% | 133.96% |
| 2013 | 0.53% | -34.57% |
| 2012 | 0.81% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.27% |
US
|
|
| 0.65% |
US
|
|
| 0.00% |
US
|
|
| 1.48% |
CN
|
|
| 0.57% |
US
|
